Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines

We investigated the anticancer potential of 5-amino-2-[p-bromophenyl]-benzoxazole [BB] which is a new benzoxazole derivative in different breast cancer cell lines. BB was applied to estrogen receptor positive [ER+] MCF-7 and receptor negative [ER-] MDA-MB cell lines and its effects were determined b...

Full description

Bibliographic Details
Main Authors: Funda Kosova, Ozlem Temiz Arpaci, Ibrahim Tuglu, Ercument Olmez, Feyzan Ozdal Kurt, Gorkem Kismali, Zeki Ari, Mustafa Arisoy
Format: Article
Language:English
Published: Society of Turaz Bilim 2022-06-01
Series:Medicine Science
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=132047
_version_ 1797328567435001856
author Funda Kosova
Ozlem Temiz Arpaci
Ibrahim Tuglu
Ercument Olmez
Feyzan Ozdal Kurt
Gorkem Kismali
Zeki Ari
Mustafa Arisoy
author_facet Funda Kosova
Ozlem Temiz Arpaci
Ibrahim Tuglu
Ercument Olmez
Feyzan Ozdal Kurt
Gorkem Kismali
Zeki Ari
Mustafa Arisoy
author_sort Funda Kosova
collection DOAJ
description We investigated the anticancer potential of 5-amino-2-[p-bromophenyl]-benzoxazole [BB] which is a new benzoxazole derivative in different breast cancer cell lines. BB was applied to estrogen receptor positive [ER+] MCF-7 and receptor negative [ER-] MDA-MB cell lines and its effects were determined by histopathological examinations, viability test [MTT], immunocytochemistry assays [Tunnel, VEGF and eNOS]. Moreover, its effects on apoptozis-related proteins such as Apaf-1, cytochrome C, caspase-3, bcl-2 and NF-κB were examined by western blot. Histopathological examinations showed that BB killed many cells for both cancer cell line while the cells lost their adhesion in MCF-7 and lost their adhesion and epiteloid morphology in MDA-MB. MTT analyses demonstrated that BB caused a clear dose depended toxic effect for both cell types. BB application resulted in an increase labeled apoptotic cells after Tunnel staining which was more obvious for MDA-MB compared to that of MCF-7. VEGF staining was decreased after BB application in both cell lines. The decrease of VEGF staining was clearer for MDA-MB compared to that of MCF-7. The status of oxidative stress was shown by eNOS immunocytochemistry which was increase after BB application in both cell lines. The levels of Apaf-1 and bcl-2 were found to be similar while caspase 9 and NF-κB levels were decreased compared to the control group after BB application for both cell lines. On the other hand, cytochrome C levels were slightly increased in MCF-7 cells while this increase was found very obvious in MDA-MB cell lines in BB groups. In conclusion, BB which is a new benzoxazole derivative have shown significant anticancer effects by increasing apoptosis and decreasing angiogenesis in MCF-7 or MDA-MB breast cancer cell lines. These effects of BB seem to be more prominent for [ER-] MDA-MB cell lines which mimic more aggressive type of breast cancer. These results suggest that BB may be useful to treat [ER-] breast cancers and may be added to treatment protocols. [Med-Science 2022; 11(2.000): 825-30]
first_indexed 2024-03-08T06:53:34Z
format Article
id doaj.art-fda1b39683c84a23bb31167e52bd5e79
institution Directory Open Access Journal
issn 2147-0634
language English
last_indexed 2024-03-08T06:53:34Z
publishDate 2022-06-01
publisher Society of Turaz Bilim
record_format Article
series Medicine Science
spelling doaj.art-fda1b39683c84a23bb31167e52bd5e792024-02-03T06:40:28ZengSociety of Turaz BilimMedicine Science2147-06342022-06-011128253010.5455/medscience.2021.10.337132047Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell linesFunda Kosova0Ozlem Temiz Arpaci1Ibrahim Tuglu2Ercument Olmez3Feyzan Ozdal Kurt4Gorkem Kismali5Zeki Ari6Mustafa Arisoy7Celal Bayar Unv Health Campus Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 06100, Tandogan, Ankara, Turkey Department of Histology and Embryology of Celal Bayar University Medical Faculty, Manisa, Turkey Department of Pharmacology of Celal Bayar University Medical Faculty, Manisa, Turkey Department of Biology of Celal Bayar University Science and Art Faculty, Manisa, Turkey Department of Biochemistry of Ankara University Veterinary Faculty, Ankara, Turkey Department of Medical Biochemistry of Celal Bayar University Medical Faculty, Manisa, Turkey Drogsan Pharmaceuticals, RD Department, Gazi Universitesi Golbasi Yerleskesi, Teknoplaza Binasi, B Blok BB10, 06830, Golbasi Ankara, TurkeyWe investigated the anticancer potential of 5-amino-2-[p-bromophenyl]-benzoxazole [BB] which is a new benzoxazole derivative in different breast cancer cell lines. BB was applied to estrogen receptor positive [ER+] MCF-7 and receptor negative [ER-] MDA-MB cell lines and its effects were determined by histopathological examinations, viability test [MTT], immunocytochemistry assays [Tunnel, VEGF and eNOS]. Moreover, its effects on apoptozis-related proteins such as Apaf-1, cytochrome C, caspase-3, bcl-2 and NF-κB were examined by western blot. Histopathological examinations showed that BB killed many cells for both cancer cell line while the cells lost their adhesion in MCF-7 and lost their adhesion and epiteloid morphology in MDA-MB. MTT analyses demonstrated that BB caused a clear dose depended toxic effect for both cell types. BB application resulted in an increase labeled apoptotic cells after Tunnel staining which was more obvious for MDA-MB compared to that of MCF-7. VEGF staining was decreased after BB application in both cell lines. The decrease of VEGF staining was clearer for MDA-MB compared to that of MCF-7. The status of oxidative stress was shown by eNOS immunocytochemistry which was increase after BB application in both cell lines. The levels of Apaf-1 and bcl-2 were found to be similar while caspase 9 and NF-κB levels were decreased compared to the control group after BB application for both cell lines. On the other hand, cytochrome C levels were slightly increased in MCF-7 cells while this increase was found very obvious in MDA-MB cell lines in BB groups. In conclusion, BB which is a new benzoxazole derivative have shown significant anticancer effects by increasing apoptosis and decreasing angiogenesis in MCF-7 or MDA-MB breast cancer cell lines. These effects of BB seem to be more prominent for [ER-] MDA-MB cell lines which mimic more aggressive type of breast cancer. These results suggest that BB may be useful to treat [ER-] breast cancers and may be added to treatment protocols. [Med-Science 2022; 11(2.000): 825-30]http://www.ejmanager.com/fulltextpdf.php?mno=132047benzoxazole derivativebreast cancerapoptosisangiogenesis
spellingShingle Funda Kosova
Ozlem Temiz Arpaci
Ibrahim Tuglu
Ercument Olmez
Feyzan Ozdal Kurt
Gorkem Kismali
Zeki Ari
Mustafa Arisoy
Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
Medicine Science
benzoxazole derivative
breast cancer
apoptosis
angiogenesis
title Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
title_full Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
title_fullStr Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
title_full_unstemmed Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
title_short Anticancer effects of a newly-synthesized benzoxazole-derived 5-amino-2- [P-bromophenyl]-benzoxazole in breast cancer cell lines
title_sort anticancer effects of a newly synthesized benzoxazole derived 5 amino 2 p bromophenyl benzoxazole in breast cancer cell lines
topic benzoxazole derivative
breast cancer
apoptosis
angiogenesis
url http://www.ejmanager.com/fulltextpdf.php?mno=132047
work_keys_str_mv AT fundakosova anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT ozlemtemizarpaci anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT ibrahimtuglu anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT ercumentolmez anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT feyzanozdalkurt anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT gorkemkismali anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT zekiari anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines
AT mustafaarisoy anticancereffectsofanewlysynthesizedbenzoxazolederived5amino2pbromophenylbenzoxazoleinbreastcancercelllines